Industry Corner Live With BioBeat CEO Arik Ben Ishay

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Health Technology

Background:

• Hypertension impacts nearly 47% of US adults, with traditional cuff-based monitoring often insufficient for effective treatment.
• Challenges include patient noncompliance and white coat syndrome, limiting longitudinal data acquisition.
• Existing methods provide intermittent readings, hindering precise medication management.

Purpose of the Study:

• To introduce a novel, cuffless ambulatory blood pressure monitoring (ABPM) system for continuous hypertension assessment.
• To highlight the system's capability in capturing longitudinal physiological data.
• To present a data-driven approach for personalized chronic hypertension management.

Main Methods:

• Utilized an FDA-cleared, cuffless ABPM system with a proprietary photoplethysmography (PPG) disposable patch.
• Continuously captured 13 vital signs over a 24-hour period.
• Integrated real-time physiological data with patient-logged behavioral events via a cloud-based platform.

Main Results:

• The PPG-based system provides continuous, high-fidelity monitoring as an alternative to intermittent oscillometric testing.
• Enabled precise medication titration through integrated physiological and behavioral data.
• Demonstrated adoption in over 160 hospitals and numerous pharmaceutical clinical trials.

Conclusions:

• The transition to continuous, sensor-based monitoring represents a paradigm shift in cardiovascular care.
• This technology facilitates personalized, data-driven management of chronic hypertension.
• Offers a superior alternative for longitudinal hypertension assessment and treatment optimization.